KVK-Tech Completes FDA REMS Inspection with No Observations
KVK-Tech said it completed an FDA REMS inspection with no observations.
Developer and manufacturer of FDA-approved generic and specialty brand medicines, including Lomaira (phentermine hydrochloride), produced in the United States at its Newtown, Pennsylvania facility.
KVK-Tech said it completed an FDA REMS inspection with no observations.
Chief Executive Officer